Market Place
Sourcing Support
Portage Biotech Reports Fiscal Quarter Results And Business Update
27 Aug 2024 //
GLOBENEWSWIRE
Portage Biotech Reports FY-End 2024 Results And Business Update
15 Aug 2024 //
GLOBENEWSWIRE
Portage Biotech Announces 1-for-20 Reverse Stock Split
13 Aug 2024 //
GLOBENEWSWIRE
Portage Biotech To Expand Strategic Alternatives Evaluation
12 Apr 2024 //
GLOBENEWSWIRE
Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares
26 Mar 2024 //
GLOBENEWSWIRE
Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023
28 Feb 2024 //
GLOBENEWSWIRE
Portage Biotech Reports Business and Strategic Update
04 Jan 2024 //
GLOBENEWSWIRE
Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023
28 Nov 2023 //
GLOBENEWSWIRE
Portage Biotech Presents Updates on its iNKT and Adenosine programs
06 Nov 2023 //
GLOBENEWSWIRE
Portage Biotech Announces $6.0 Million Registered Direct Offering
29 Sep 2023 //
GLOBENEWSWIRE
Portage to Participate in Panel Discussion at the Cantor Healthcare Conference
20 Sep 2023 //
GLOBENEWSWIRE
Portage Biotech Announces Collaboration with Merck to Evaluate Adenosine
05 Sep 2023 //
GLOBENEWSWIRE
Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023
30 Aug 2023 //
GLOBENEWSWIRE
Portage Biotech Reports Fiscal Year-Ended March 31, 2023 Financial Results
31 Jul 2023 //
GLOBENEWSWIRE
Portage Biotech Announces First Patient Dosed in Phase 1a Trial of PORT-6
26 Jun 2023 //
GLOBENEWSWIRE
Portage Biotech Reports Updated Interim Data for Lead iNKT Engager, PORT-2
05 Jun 2023 //
GLOBENEWSWIRE
Portage Biotech to Participate in Panel Discussion During 2023 BIO Conference
01 Jun 2023 //
GLOBENEWSWIRE
Portage Biotech Announces Upcoming PORT-2 Poster Presentation at 2023 ASCO
26 Apr 2023 //
GLOBENEWSWIRE
Portage Biotech to Present at Oppenheimer Annual Healthcare Conference
07 Mar 2023 //
GLOBENEWSWIRE
Portage Hosting Event on Targeting the Adenosine Pathway in Cancer
27 Feb 2023 //
GLOBENEWSWIRE
Portage Biotech to Participate in Citi`s 2023 Virtual Oncology Leadership Summit
15 Feb 2023 //
GLOBENEWSWIRE
Portage Biotech Announces Results for Fiscal Quarter Ended September 30, 2022
29 Nov 2022 //
GLOBENEWSWIRE
Portage Presents Updated Data on the Ph 1/2 Trial Evaluating PORT-2 at (SITC)
10 Nov 2022 //
GLOBENEWSWIRE
Portage Biotech Announces Clinical Trial Collaboration Agreement with Merck
08 Nov 2022 //
GLOBENEWSWIRE
Portage Biotech Provides Research and Development Update
14 Sep 2022 //
GLOBENEWSWIRE
Portage Biotech Announces Results for Fiscal Quarter Ended June 30, 2022
29 Aug 2022 //
GLOBENEWSWIRE
Portage Biotech Announces Leadership Updates
18 Aug 2022 //
GLOBENEWSWIRE
Portage Biotech Announces Results for Fiscal Year Ended March 31, 2022
01 Aug 2022 //
GLOBENEWSWIRE
Portage acquires adenosine receptor-focused Tarus
08 Jul 2022 //
FIERCEBIOTECH
Portage Biotech Bolsters Pipeline with Acquisition of 4 Candidates
06 Jul 2022 //
GLOBENEWSWIRE
Portage Biotech Summarizes Data Presented at ASCO 2022 from Ongoing PORT-2 Study
06 Jun 2022 //
GLOBENEWSWIRE
Portage Biotech (PRTG) Stock: Why The Price Gained Over 6% Today
23 May 2022 //
PULSE2
Portage Biotech Enters Cooperative R&D Agreement with U.S. National Cancer
25 Apr 2022 //
GLOBENEWSWIRE
portage biotech highlights promising data presented on port-5 at aacr 2022
13 Apr 2022 //
PRESS RELEASE
Portage Bio Presents Data on STING-Activating Therapy, PORT-5 (STI-001) at AACR
13 Apr 2022 //
GLOBENEWSWIRE
Portage Biotech Provides Update on Clinical-Stage and Development Programs
31 Mar 2022 //
GLOBENEWSWIRE
Portage Biotech says Presentation of PORT-5 (STI-001) Late-Breaking Data
09 Mar 2022 //
GLOBENEWSWIRE
Portage Biotech Announces Q3 Financial Results and Provides Business Update
24 Feb 2022 //
GLOBENEWSWIRE
Portage Biotech Announces Financial Results and Provides Business
23 Nov 2021 //
GLOBENEWSWIRE
Portage Biotech to Present at the Piper Sandler 33rd AHC
22 Nov 2021 //
GLOBENEWSWIRE
Portage Biotech Highlights Promising Efficacy and Survival Data
15 Nov 2021 //
GLOBENEWSWIRE
Portage Biotech Hosting Key Opinion Leader Webinar on How iNKT Agonists
10 Nov 2021 //
GLOBENEWSWIRE
Portage Biotech Announces Results for First Quarter of 2022 Fiscal Year
30 Aug 2021 //
GLOBENEWSWIRE
Portage Biotech Highlights First Patient Dosed in IMP-MEL Study of PORT-2
05 Aug 2021 //
GLOBENEWSWIRE
